Jacobs Levy Equity Management, Inc Editas Medicine, Inc. Transaction History

Jacobs Levy Equity Management, Inc

  • $23.9 Billion
  • Q3 2025

A detailed history of Jacobs Levy Equity Management, Inc transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 800,023 shares of EDIT stock, worth $2.08 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
800,023
Previous 92,842 761.7%
Holding current value
$2.08 Million
Previous $204,000 1260.78%
% of portfolio
0.01%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 17, 2025
BUY
$2.2 - $3.52 $1.56 Million - $2.49 Million
707,181 Added 761.7%
800,023 $2.78 Million
Q2 2025

Aug 14, 2025
BUY
$0.98 - $2.35 $90,985 - $218,178
92,842 New
92,842 $204,000
Q4 2024

Feb 14, 2025
BUY
$1.2 - $3.76 $214,290 - $671,442
178,575 Added 33.7%
708,409 $899,000
Q3 2024

Nov 14, 2024
BUY
$3.39 - $5.96 $1.03 Million - $1.8 Million
302,652 Added 133.22%
529,834 $1.81 Million
Q2 2024

Aug 14, 2024
BUY
$4.67 - $7.28 $504,556 - $786,545
108,042 Added 90.68%
227,182 $1.06 Million
Q1 2024

May 15, 2024
SELL
$7.03 - $11.07 $1.16 Million - $1.83 Million
-165,688 Reduced 58.17%
119,140 $884,000
Q4 2023

Feb 14, 2024
BUY
$6.25 - $11.11 $1.26 Million - $2.24 Million
201,732 Added 242.77%
284,828 $2.89 Million
Q3 2023

Nov 16, 2023
BUY
$6.92 - $9.31 $448,014 - $602,748
64,742 Added 352.74%
83,096 $648,000
Q2 2023

Aug 14, 2023
BUY
$6.36 - $11.47 $116,731 - $210,520
18,354 New
18,354 $151,000
Q4 2022

Feb 14, 2023
SELL
$8.32 - $13.21 $765,731 - $1.22 Million
-92,035 Reduced 85.9%
15,103 $133,000
Q3 2022

Nov 15, 2022
BUY
$12.16 - $19.42 $1.3 Million - $2.08 Million
107,138 New
107,138 $1.31 Million
Q2 2022

Aug 15, 2022
SELL
$9.99 - $21.35 $755,833 - $1.62 Million
-75,659 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$14.08 - $27.63 $1.07 Million - $2.09 Million
75,659 New
75,659 $1.44 Million
Q1 2021

May 17, 2021
SELL
$39.71 - $90.58 $2.75 Million - $6.28 Million
-69,345 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$27.07 - $84.35 $559,672 - $1.74 Million
-20,675 Reduced 22.97%
69,345 $4.86 Million
Q3 2020

Nov 16, 2020
SELL
$28.06 - $37.16 $630,620 - $835,133
-22,474 Reduced 19.98%
90,020 $2.53 Million
Q2 2020

Aug 17, 2020
BUY
$18.5 - $34.34 $832,925 - $1.55 Million
45,023 Added 66.73%
112,494 $3.33 Million
Q1 2020

May 15, 2020
BUY
$14.88 - $32.78 $504,342 - $1.11 Million
33,894 Added 100.94%
67,471 $1.34 Million
Q4 2019

Feb 14, 2020
BUY
$19.49 - $32.63 $654,415 - $1.1 Million
33,577 New
33,577 $994,000

Others Institutions Holding EDIT

# of Institutions
226
Shares Held
46.2M
Call Options Held
841K
Put Options Held
304K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $179M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email